PremiumThe FlyPsychedelic: Atai, Enveric, Incannex and Relmada report quarterly results BetterLife Pharma Advances BETR-001 for Psychiatric Treatment BetterLife provides update of mechanism of action of BETR-001 PremiumThe FlyBetterLife appoints Steven Sangha to board of directors BetterLife Pharma Converts Debt to Strengthen Financial Position BetterLife announces debt conversions PremiumCompany AnnouncementsBetterLife Pharma Unveils Non-Hallucinogenic Mental Health Treatment BetterLife Pharma Updates Ownership Details and Advances Neurological Treatments BetterLife Pharma Secures Funding for Mental Health Treatments